Literature DB >> 6292896

IgA interaction with the asialoglycoprotein receptor.

R J Stockert, M S Kressner, J C Collins, I Sternlieb, A G Morell.   

Abstract

IgA present in normal human serum reacts with the hepatic receptor specific for asialoglycoproteins as demonstrated by inhibition of receptor-mediated erythroagglutination. Inhibition is reversibly abolished by the oxidation of the galactose or N-acetylgalactosamine residues of IgA with galactose oxidase. The site of receptor recognition appears to be the O-glycosidically linked oligosaccharides present on the hinge region of the IgAI subtype of IgA. The demonstration of a specific binding, in vitro, of IgA by the hepatic receptor suggests that the uptake of polymeric IgA by the liver in vivo may be mediated by this reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292896      PMCID: PMC347093          DOI: 10.1073/pnas.79.20.6229

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A hepatic receptor of avian origin capable of binding specifically modified glycoproteins.

Authors:  J Lunney; G Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

Review 2.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

3.  Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units.

Authors:  J Baenziger; S Kornfeld
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins.

Authors:  R L Hudgin; W E Pricer; G Ashwell; R J Stockert; A G Morell
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

5.  The binding of desialylated glycoproteins by plasma membranes of rat liver.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

6.  A membrane receptor protein for asialoglycoproteins.

Authors:  W E Pricer; R L Hudgin; G Ashwell; R J Stockert; A G Morell
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  A simple technique for the isolation of orosomucoid from normal and pathological sera.

Authors:  P H Whitehead; H G Sammons
Journal:  Biochim Biophys Acta       Date:  1966-07-27

8.  Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.

Authors:  J S Marshall; A M Green; J Pensky; S Williams; A Zinn; D M Carlson
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

9.  Mammalian hepatic lectin.

Authors:  R J Stockert; A G Morell; I H Scheinberg
Journal:  Science       Date:  1974-10-25       Impact factor: 47.728

10.  A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains.

Authors:  H M Grey; C A Abel; W J Yount; H G Kunkel
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 2.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 3.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 4.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

5.  Clearance kinetics and tissue distribution of aggregated human serum IgA in rats.

Authors:  W M Bogers; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Aberrant glycosylation of IgA from patients with IgA nephropathy.

Authors:  D Baharaki; M Dueymes; R Perrichot; C Basset; R Le Corre; J Clèdes; P Youinou
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

7.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Authors:  M Tomana; J Novak; B A Julian; K Matousovic; K Konecny; J Mestecky
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 8.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

9.  Circulating IgA immune complexes and skin IgA deposits in liver disease. Relation to liver histopathology.

Authors:  A van de Wiel; R M Valentijn; H J Schuurman; M R Daha; R J Hené; L Kater
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

10.  Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.

Authors:  J Sancho; E González; F Rivera; J F Escanero; J Egido
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.